Pfizer weighs $15 billion sale of consumer healthcare business

(Reuters) - Pfizer said on Tuesday it was considering the sale or spin-off of its consumer healthcare business, shaking up the industry and potentially putting a headache pill to lip balm operation worth some $15 billion up for grabs.

Source: Reuters: Health - October 10, 2017 Category: Consumer Health News Tags: healthNews Source Type: news